|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||
| Depreciation and amortization | |||||
| Loss on rental units and other assets | |||||
| Loss (gain) on sale of former rental assets | |||||
| Provision for sales revenue returns and doubtful accounts | |||||
| Provision for inventory losses | |||||
| Loss on purchase commitments | |||||
| Stock-based compensation expense | |||||
| Deferred income taxes | |||||
| Change in fair value of earnout liability | |||||
| Impairment charges | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Income tax receivable | |||||
| Prepaid expenses and other current assets | |||||
| Operating lease right-of-use asset | |||||
| Other noncurrent assets | |||||
| Accounts payable and accrued expenses | |||||
| Accrued payroll | |||||
| Warranty reserve | |||||
| Deferred revenue | |||||
| Income tax payable | |||||
| Operating lease liability | |||||
| Earnout liability | |||||
| Net cash (used in) provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of available-for-sale securities | |||||
| Maturities of available-for-sale securities | |||||
| Investment in intangible assets | |||||
| Investment in property and equipment | |||||
| Production and purchase of rental equipment | |||||
| Proceeds from sale of former assets | |||||
| Acquisition of business, net of cash acquired | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from stock options exercised | |||||
| Proceeds from employee stock purchases | |||||
| Payment of employment taxes related to release of restricted stock | |||||
| Payments of accrued earnout | |||||
| Proceeds from issuance of common stock from securities purchase agreement | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rates on cash | |||||
| Net decrease in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Supplemental disclosures of cash flow information | |||||
| Cash paid (received) during the period for income taxes, net of refunds received | |||||
| Supplemental disclosure of non-cash transactions | |||||
| Accrued value of earnout related to acquisition | |||||
| Property and equipment in accounts payable and accrued expenses | |||||
Loading...